Patent Expirations: The Calm Before the Storm
the great battle between pharma companies and their generic competitors, drug delivery technologies have an outstanding track record. Numerous large pharmaceutical companies have successfully relaunched blockbusters as novel formulations with an enhanced method of delivery, orodispersible and sustained-release dosage forms being the most popular. Indeed, life-cycle management was the single most important factor that drove the rapid growth of the delivery sector during the 1990s and the first years of this decade. Yet more recently, involvement with pharma life-cycle management has been conspicuous in its absence from the core business strategies of delivery companies, where many believe even its mention nowadays can trouble investors.
View Full Article
